Comparison of the therapeutic effect of allopurinol versus placebo on clinical signs and symptoms in patients with manic bipolar disorder
Phase 2
Recruiting
- Conditions
- Manic bipolar disorder.Manic episode
- Registration Number
- IRCT201710089014N193
- Lead Sponsor
- Vice-chancellor for Research and Technology, Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age of 18 to 45 years; manic bipolar disorder; Score of YMRS equal to or greater than28.
Exclusion criteria: Pregnancy; breastfeeding; sensitivity to allopurinol; mental disability; diabetes; hypertension; hypothyroiditis; hyperthyroiditis; convulsion; liver failure; renal failure.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of clinical signs and symptoms. Timepoint: Before intervention and one, two, three, and four weeks after intervention. Method of measurement: Using YMRS questionnaire.
- Secondary Outcome Measures
Name Time Method